Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.51 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.51 |
| ▸ | CA12 | O43570 | 2/20 | 0.51 |
| ▸ | CA9 | Q16790 | 2/20 | 0.51 |
| ▸ | CA4 | P22748 | 1/20 | 0.51 |
| ▸ | CA6 | P23280 | 1/20 | 0.51 |
| ▸ | CA5A | P35218 | 1/20 | 0.51 |
| ▸ | CA7 | P43166 | 1/20 | 0.51 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.51 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | TTR | P02766 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14952780 | 0.84 | HCAR2 (0.61) | HCAR2LMNAALDH1A1AKR1B10AKR1B1 | |
| SCHEMBL34054 | 0.79 | HCAR2 (0.65) | HCAR2LMNAALDH1A1AKR1B10AKR1B1 | |
| SCHEMBL812094 | 0.79 | HCAR2 (0.65) | HCAR2LMNAALDH1A1AKR1B10AKR1B1 | |
| SCHEMBL28230354 | 0.79 | HCAR2 (0.65) | HCAR2LMNAALDH1A1AKR1B10AKR1B1 | |
| Benzene SCHEMBL28307095 | 0.79 | HCAR2 (0.65) | HCAR2LMNAALDH1A1AKR1B10AKR1B1 | |
| SCHEMBL6451169 | 0.79 | HCAR2 (0.56) | HCAR2LMNAALDH1A1AKR1B10AKR1B1 | |
| SCHEMBL337504 | 0.79 | HCAR2 (0.89) | HCAR2LMNAALDH1A1AKR1B10AKR1B1 | |
| SCHEMBL337503 | 0.79 | HCAR2 (0.89) | HCAR2LMNAALDH1A1AKR1B10AKR1B1 | |
| SCHEMBL9395526 | 0.79 | HCAR2 (0.69) | HCAR2LMNAALDH1A1AKR1B10AKR1B1 | |
| SCHEMBL357565 | 0.79 | HCAR2 (0.89) | HCAR2LMNAALDH1A1AKR1B10AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024198014-A1 | CONCRETE MODIFYING AGENT AND PREPARATION METHOD THEREFOR, CONCRETE ADMIXTURE AND CONCRETE COMPOSITION | 石家庄市长安育才建材有限公司 | 2024-10-03 | — | — | WO | claimed |
| WO-2024198014-A1 | CONCRETE MODIFYING AGENT AND PREPARATION METHOD THEREFOR, CONCRETE ADMIXTURE AND CONCRETE COMPOSITION | 石家庄市长安育才建材有限公司 | 2024-10-03 | — | — | WO | disclosed |
| US-20230174506-A1 | (DI)AMINATION OF ACTIVATED ALLENE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR SYNTHESIS OF THE SAME | PURDUE RESEARCH FOUNDATION | 2023-06-08 | — | — | US | disclosed |
| CN-113874079-A | Bridged tricyclic carbamoylpyridone compounds and pharmaceutical use thereof | 吉利德科学公司 | 2021-12-31 | — | — | CN | disclosed |
| CN-110408235-A | A kind of dye composite and application thereof | HANGZHOU YIKANG NEW MAT CO LTD | 2019-11-05 | — | — | CN | disclosed |
| US-20180118770-A1 | N-Heterocyclic Phosphines | THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS | 2018-05-03 | — | — | US | disclosed |
| CN-1146587-C | Compositions having ethylenic backbone and benzylic, allylic, or ether-containing side-chains, oxygen scavenging compositions containing the same, and polymer | �з��ﰺ��ѧ��˾ | 2004-04-21 | — | — | CN | disclosed |
| CN-1187206-A | Compositions having ethylenic backbone and benzylic, allylic, or ether-containing side-chains, oxygen scavenging compositions containing the same, and polymer | CHEVRON CHEM CO (US) | 1998-07-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118770-A1 | N-Heterocyclic Phosphines | NANP, PPIP5K2, PHPT1 | HCAR2 2793/4885LMNA 3601/4885ALDH1A1 4621/4885 |
| US-20230174506-A1 | (DI)AMINATION OF ACTIVATED ALLENE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR SYNTHESIS OF THE SAME | NAAA, PAM, AANAT | HCAR2 1404/4885LMNA 1994/4885ALDH1A1 583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.